Chester County News and Community Website
Are you looking for Chester County businesses that are traded on the Nasdaq Stock Market? Would you love adding a Chester County business to your investment portfolio or 401k? The process of building a properly diversified portfolio, which includes investments in local businesses, is an important personal financial strategy.
Here you will find news and updates from Chester County businesses that are listed on the Nasdaq Stock Market. There is a growing appetite for real, local business news about publicly traded companies. MyChesCo features local business news from around Chester County. Moreover, we provide in-depth articles about Chester County’s dynamic business and economic scene, including tips for small biz owners, marketing, management, startups, entrepreneurship, and more.
WAYNE, PA — Aclaris Therapeutics Inc. (Nasdaq: ACRS) has completed patient enrollment in its Phase 2 trial of bosakitug in patients with moderate-to-severe atopic dermatitis, marking a development milestone for …
Aclaris Completes Enrollment in Phase 2 Trial of Bosakitug for Atopic Dermatitis Read More
MALVERN, PA — Neuronetics, Inc. (Nasdaq: STIM) reported higher fourth-quarter and full-year 2025 revenue, narrowed its losses, posted positive operating cash flow in the fourth quarter, and said Dan Reuvers …
Neuronetics Reports Higher Revenue, Narrows Loss, Sets 2026 Outlook Read More MALVERN, PA — Neuronetics Inc. (Nasdaq: STIM) said it has appointed Dan Reuvers as president and chief executive officer, effective Monday, succeeding Keith Sullivan, who will step down the same …
Neuronetics Appoints Dan Reuvers as CEO, Succeeding Keith Sullivan Read More
WAYNE, PA — BTCS Inc. (Nasdaq: BTCS) said it has revised its 2026 annual performance incentive program to place greater emphasis on gross profit, shifting away from a model previously …
BTCS Revises 2026 Incentive Plan to Emphasize Profitability Read More
WAYNE, PA — Palvella Therapeutics Inc. (Nasdaq: PVLA) said the European Patent Office has granted a patent covering its lead product candidate QTORIN 3.9% rapamycin gel, extending intellectual property protection …
European Patent Office Grants Palvella Patent for QTORIN Rapamycin Read More
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) reported financial results for the fourth quarter and full year ended December 31, 2025, citing growth in sales of its dermatology …
Verrica Pharmaceuticals Reports 2025 Results and YCANTH Sales Growth Read More
MALVERN, PA — TELA Bio Inc. (NASDAQ: TELA) said it will report financial results for the fourth quarter and full year ended December 31, 2025, on Tuesday, March 24, 2026.
TELA Bio to Report Fourth Quarter and Full-Year 2025 Results March 24 Read More WAYNE, PA — Palvella Therapeutics Inc. (Nasdaq: PVLA) announced the launch of “BEYOND mLM,” a disease awareness campaign and website designed to provide educational resources for patients, caregivers, and healthcare …
Palvella Therapeutics Launches Awareness Campaign for Rare Lymphatic Disease Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) announced that it will host a conference call and live webcast Wednesday to discuss its financial results for the fourth quarter …
Verrica Pharmaceuticals Schedules Conference Call to Discuss 2025 Results Read More
EXTON, PA — Omega Flex, Inc. (NASDAQ: OFLX) reported net sales of $98,296,000 for 2025, down from $101,681,000 in 2024, as lower unit volumes weighed on performance.
Omega Flex Reports Lower Sales and Net Income for 2025 Read More